Addition of hyaluronic acid to the FIB‐4 liver fibrosis score improves prediction of incident cirrhosis and hepatocellular carcinoma in type 2 diabetes: The Edinburgh Type 2 Diabetes Study

• Main Authors: Sheila M. Grecian (Author), Stela McLachlan (Author), Jonathan A. Fallowfield (Author), Peter C. Hayes (Author), Indra Neil Guha (Author), Joanne R. Morling (Author), Stephen Glancy (Author), Rachel M. Williamson (Author), Rebecca M. Reynolds (Author), Brian M. Frier (Author), Nicola N. Zammitt (Author), Jackie F. Price (Author), Mark W. J. Strachan (Author)
• Format: Book
• Published: Wiley, 2021-10-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background Type 2 diabetes (T2D) is associated with increased risk of progression to cirrhosis and hepatocellular carcinoma (HCC) in people with chronic liver diseases, particularly non‐alcoholic fatty liver disease (NAFLD). However, the absolute risk of progression is low. So, it is crucia...